HBI Deals+Insights / News
Dr Lal Pathlabs, India's second largest medical laboratory group by revenue, saw revenue growth of 15.7% and EBITDA rise 12.2% in the year to March 31, 2018. The group's CEO says balance sheet cash will primarily be used for M&A going forward.